Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 7

Results: 26

David Haslam. Interview by Asher Mullard.

Published in:

2013

By:

Asher, Mullard;
Haslam, David

Publication type:

Interview

Metabolic disorders: Betatrophin boosts β-cells.

Published in:

2013

By:

Crunkhorn, Sarah

Publication type:

journal article

Two approvals boost melanoma arsenal.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 494, doi. 10.1038/nrd4073
Publication type:: Article

Strategies for optimizing the response of cancer and normal tissues to radiation.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 526, doi. 10.1038/nrd4003

By:

Moding, Everett J.;
Kastan, Michael B.;
Kirsch, David G.

Publication type:

Article

Optimizing the use of CROs by academia and small companies.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 487, doi. 10.1038/nrd4057

By:

Lane, Rachel F.;
Friedman, Lauren G.;
Keith, Curtis;
Braithwaite, Steven P.;
Frearson, Julie A.;
Lowe, David A.;
Longo, Frank M.;
Refolo, Lorenzo M.;
Watterson, D. Martin;
Tsaioun, Katya;
Shineman, Diana W.;
Fillit, Howard M.

Publication type:

Article

Deal watch: AbbVie invests in pioneering celiac disease therapy.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 497, doi. 10.1038/nrd4063

By:

Crunkhorn, Sarah

Publication type:

Article

David Haslam.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 500, doi. 10.1038/nrd4053

By:

Asher, Mullard

Publication type:

Article

Cancer: Preserving fertility during chemotherapy.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 506, doi. 10.1038/nrd4062

By:

Charlotte, Harrison

Publication type:

Article

First-in-class insomnia drug on the brink of approval nod.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 492, doi. 10.1038/nrd4067

By:

Osborne, Randy

Publication type:

Article

New checkpoint inhibitors ride the immunotherapy tsunami.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 489, doi. 10.1038/nrd4066

By:

Mullard, Asher

Publication type:

Article

Market watch: Upcoming market catalysts in Q3 2013.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 496, doi. 10.1038/nrd4056

By:

Roybal, Dane

Publication type:

Article

Metabolic disorders: Betatrophin boosts β-cells.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 504, doi. 10.1038/nrd4058

By:

Crunkhorn, Sarah

Publication type:

Article

Anticancer drugs: Cracking the combination.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 505, doi. 10.1038/nrd4071

By:

Bordon, Yvonne

Publication type:

Article

Clinical trials: Exenatide provides benefit in Parkinson's disease.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 506, doi. 10.1038/nrd4060

By:

Charlotte, Harrison

Publication type:

Article

Anticancer drugs: A new approach for blocking KRAS.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 506, doi. 10.1038/nrd4054

By:

Tse, Man Tsuey

Publication type:

Article

In this issue.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 485, doi. 10.1038/nrd4069
Publication type:: Article

New hope for dry AMD?

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 501, doi. 10.1038/nrd4038

By:

Evans, James B.;
Syed, Basharut A.

Publication type:

Article

Cancer: IL-22: linking inflammation and cancer.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 504, doi. 10.1038/nrd4065

By:

Harrison, Charlotte

Publication type:

Article

Cardiovascular disease: Rejuvenating the ageing heart.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 503, doi. 10.1038/nrd4064

By:

Flemming, Alexandra

Publication type:

Article

FDA asks for input on antibiotic drug development.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 494, doi. 10.1038/nrd4074
Publication type:: Article

Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 507, doi. 10.1038/nrd4024

By:

Longo, Frank M.;
Massa, Stephen M.

Publication type:

Article

Target identification: A new target for treating progeria.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 506, doi. 10.1038/nrd4059

By:

Charlotte, Harrison

Publication type:

Article

Supreme Court rules on DNA patents.

Published in:: Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 494, doi. 10.1038/nrd4072
Publication type:: Article

United States to tackle patent trolls.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 498, doi. 10.1038/nrd4070

By:

Harrison, Charlotte

Publication type:

Article

New anti-inflammatory targets for chronic obstructive pulmonary disease.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 543, doi. 10.1038/nrd4025

By:

Barnes, Peter J.

Publication type:

Article

Neurological disorders: Identifying pathogenic pathways.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 506, doi. 10.1038/nrd4061

By:

Charlotte, Harrison

Publication type:

Article